Marie-Laure Plissonnier
Overview
Explore the profile of Marie-Laure Plissonnier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
296
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Testoni B, Roca Suarez A, Battisti A, Plissonnier M, Heil M, Fontanges T, et al.
JHEP Rep
. 2023 Sep;
5(10):100841.
PMID: 37675272
Background & Aims: Finite duration of treatment associated with HBsAg loss is the current goal for improved therapeutic approaches against chronic HBV infection, as it indicates elimination or durable inactivation...
12.
Chouik Y, Lebosse F, Plissonnier M, Lega J, Pradat P, Antonini T, et al.
iScience
. 2023 Aug;
26(8):107427.
PMID: 37575179
Bacterial infections are the most frequent precipitating event in patients with acute decompensation of cirrhosis (AD) and are associated with high mortality. Early diagnosis is challenging due to cirrhosis-related systemic...
13.
Scholtes C, Hamilton A, Plissonnier M, Charre C, Scott B, Wang L, et al.
J Clin Virol
. 2022 Apr;
150-151:105150.
PMID: 35427860
Background: The amount of HBV RNA in peripheral blood may reflect HBV covalently closed circular DNA (cccDNA) transcriptional activity within infected hepatocytes. Quantification of circulating HBV RNA (cirB-RNA) is thus...
14.
Barnault R, Verzeroli C, Fournier C, Michelet M, Redavid A, Chicherova I, et al.
Hepatology
. 2022 Mar;
76(5):1345-1359.
PMID: 35253915
Background And Aims: Netrin-1 displays protumoral properties, though the pathological contexts and processes involved in its induction remain understudied. The liver is a major model of inflammation-associated cancer development, leading...
15.
Gallard C, Lebsir N, Khursheed H, Reungoat E, Plissonnier M, Bre J, et al.
J Hepatol
. 2022 Jan;
77(1):29-41.
PMID: 35085593
Background & Aims: Over time, chronic HCV infection can lead to hepatocellular carcinoma (HCC), a process that involves changes to the liver extracellular matrix (ECM). However, the exact mechanisms by...
16.
Antonelli F, Bartolini M, Plissonnier M, Esposito A, Galotta G, Ricci S, et al.
Microorganisms
. 2020 Dec;
8(12).
PMID: 33339447
Waterlogged archaeological wood is exposed to a high risk of biological degradation during the post-excavation phases of storage and restoration. For this reason, often biocides must be used to preserve...
17.
Salerno D, Chiodo L, Alfano V, Floriot O, Cottone G, Paturel A, et al.
Gut
. 2020 Mar;
69(11):2016-2024.
PMID: 32114505
Objective: The HBV HBx regulatory protein is required for transcription from the covalently closed circular DNA (cccDNA) minichromosome and affects the epigenetic control of both viral and host cellular chromatin....
18.
Plissonnier M, Cottarel J, Piver E, Kullolli M, Centonze F, Pitteri S, et al.
Virus Res
. 2019 Aug;
271:197679.
PMID: 31398365
Hepatitis C virus (HCV) virions contain a subset of host liver cells proteome often composed of interesting virus-interacting factors. A proteomic analysis performed on double gradient-purified clinical HCV highlighted the...
19.
Plissonnier M, Herzog K, Levrero M, Zeisel M
Viruses
. 2018 Nov;
10(11).
PMID: 30380697
Hepatitis C virus (HCV) infection is a worldwide health problem and is one of the main causes of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma (HCC). Despite recent improvements, effective...
20.
Plissonnier M, Fauconnet S, Bittard H, Mougin C, Rommelaere J, Lascombe I
Oncotarget
. 2018 Jan;
8(64):107744-107762.
PMID: 29296202
Known activators of the Peroxisome Proliferator-Activated Receptor γ (PPARγ), thiazolidinediones (TZD) induce apoptosis in a variety of cancer cells through dependent and/or independent mechanisms of the receptor. We tested a...